title: Cerebral and aortic blood flow velocity patterns in preterm infants receiving prophylactic surfactant treatment.
abstract: Blood velocity in the internal carotid artery (ICA) and in the descending thoracic aorta (DAo) was investigated used Duplex-Doppler ultrasound in 14 infants of less than 30 weeks gestation, treated prophylactically with surfactant, and in 11 comparable infants with relatively mature lungs who served as controls. After surfactant administration, blood gases, pH or FiO2 were not different between the groups. Temporal mean blood velocity in the ICA was used as a relative measure of cerebral flow (TMFV-cer), and its coefficient of variation (CV-cer) was used to assess fluctuations in cerebral blood velocity. The pulsatility index (PI) in the ICA (PI-cer) and DAo (PI-DAo) was used to estimate if a left-to-right shunt was present. During surfactant instillation TMFV-cer was abnormally low and CV-cer indicated a fluctuating cerebral blood velocity. At 10 min after surfactant administration, TMFV-cer of the treated infants was higher compared to the controls, while CV-cer was stable in both groups. PI-cer and PI-DAo were abnormally high during the first hour of life after surfactant treatment, suggesting a left-to-right shunt without, however, clinical signs of a hemodynamically important ductus arteriosus. We suggest that cerebral perfusion is affected during and at 10 min after surfactant instillation. Left-to-right shunting appears to be a common event following surfactant treatment.
authors.affiliation: Department of Pediatrics, University Hospital, Leiden, The Netherlands.
authors.forename: F
authors.initials: F
authors.lastname: van Bel
authors.forename: P J
authors.initials: PJ
authors.lastname: de Winter
authors.forename: H B
authors.initials: HB
authors.lastname: Wijnands
authors.forename: M
authors.initials: M
authors.lastname: van de Bor
authors.forename: J
authors.initials: J
authors.lastname: Egberts
mesh_terms: D001013:Aorta, Thoracic / Q000000981:diagnostic imaging / Q000502:physiology*; D001688:Biological Products; D001783:Blood Flow Velocity / Q000187:drug effects; D001794:Blood Pressure; D002245:Carbon Dioxide / Q000097:blood; D002343:Carotid Artery, Internal / Q000000981:diagnostic imaging / Q000502:physiology; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature / Q000097:blood / Q000502:physiology*; D016014:Linear Models; D010100:Oxygen / Q000097:blood; D010743:Phospholipids; D011663:Pulmonary Surfactants / Q000494:pharmacology*; D012039:Regional Blood Flow / Q000187:drug effects; D014463:Ultrasonography
chemical_list: D001688:Biological Products; D010743:Phospholipids; D011663:Pulmonary Surfactants; D002245:Carbon Dioxide; C068291:poractant alfa; D010100:Oxygen